Clinical Trials Browser

Phase 1/2 × Small Cell Lung Cancer Extensive Stage × tislelizumab × Clear all

NCT06030258 2025-04-30

IN10018 Combination Therapy in Treatment-naïve ES-SCLC

Phase 1/2 Recruiting

Small Cell Lung Cancer Extensive Stage